Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 14, 2023, Xencor, Inc. held its 2023 Annual Meeting of
Stockholders. A total of 58,351,294 shares of the Company s common. | June 15, 2023
03.03.2022 - Multiple data readouts expected in 2022, including updates for all three clinical programs Ends 2021 with cash position of $219.6 million that is expected to fund operations into first quarter of 2024 BELTSVILLE, Md., March 03, 2022 (GLOBE .
NextCure Announces New Appointments to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NextCure Announces New Appointments to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BELTSVILLE, Md., Oct. 04, 2021 (GLOBE NEWSWIRE) NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related